The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer

• Ovarian cancer is the most lethal among gynecological cancers. • Carboplatin-based chemotherapy identifies as the main systemic treatment for ovarian cancer patients. • Almost one every three patients treated with carboplatin experiences hypersensitivity reactions. • Patients may experience breakt...

Descripción completa

Detalles Bibliográficos
Autores principales: Vultaggio, Alessandra, Petrella, Maria Cristina, Tomao, Federica, Nencini, Francesca, Mecheri, Valentina, Marini, Andrea, Perlato, Margherita, Vivarelli, Emanuele, De Angelis, Claudia, Ferrarini, Ilaria, Pillozzi, Serena, Matucci, Andrea, Antonuzzo, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Reports and Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651898/
https://www.ncbi.nlm.nih.gov/pubmed/34926761
http://dx.doi.org/10.1016/j.gore.2021.100880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651898/
https://www.ncbi.nlm.nih.gov/pubmed/34926761
http://dx.doi.org/10.1016/j.gore.2021.100880

Ejemplares similares